150 related articles for article (PubMed ID: 36175598)
1. SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cells.
Tang L; Peng L; Liu H; Xiao T; Gu W; Yang H; Wang H; Chen P
Med Oncol; 2022 Sep; 39(12):214. PubMed ID: 36175598
[TBL] [Abstract][Full Text] [Related]
2. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
3. SPLUNC1 knockout enhances LPS-induced lung injury by increasing recruitment of CD11b+Gr-1+ cells to the spleen of mice.
Zhang H; Li X; Liao S; Wang H; Chen P; Zhu G; Luo Y; Li G; Zhou Y
Oncol Rep; 2018 Jan; 39(1):358-366. PubMed ID: 29115527
[TBL] [Abstract][Full Text] [Related]
4. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1.
Chen P; Guo X; Zhou H; Zhang W; Zeng Z; Liao Q; Li X; Xiang B; Yang J; Ma J; Zhou M; Peng S; Xiang J; Li X; L E CW; Xiong W; McCarthy JB; Li G
PLoS One; 2013; 8(3):e56929. PubMed ID: 23472073
[TBL] [Abstract][Full Text] [Related]
5. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
[TBL] [Abstract][Full Text] [Related]
6. SPLUNC1 and MLL3 regulate cancer stem cells in nasopharyngeal carcinoma.
Bian S; Wang Z; Chen Y; Li R
J BUON; 2019; 24(4):1700-1705. PubMed ID: 31646828
[TBL] [Abstract][Full Text] [Related]
7. New insights on the palate, lung, and nasal epithelium clone (PLUNC) proteins: Based on molecular and functional analysis of its homolog of YH1/SPLUNC1.
Liu H; Zhang X; Wu J; French SW; He Z
Exp Mol Pathol; 2016 Jun; 100(3):363-9. PubMed ID: 26654795
[TBL] [Abstract][Full Text] [Related]
8. Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain.
Zhou HD; Li GY; Yang YX; Li XL; Sheng SR; Zhang WL; Zhao J
Mol Immunol; 2006 Apr; 43(11):1864-71. PubMed ID: 16364440
[TBL] [Abstract][Full Text] [Related]
9. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of LOX-1
Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
[TBL] [Abstract][Full Text] [Related]
11. Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese.
Yew PY; Mushiroda T; Kiyotani K; Govindasamy GK; Yap LF; Teo SH; Lim PV; Govindaraju S; Ratnavelu K; Sam CK; Yap YY; Khoo AS; Pua KC; Nakamura Y; ; Ng CC
Mol Carcinog; 2012 Oct; 51 Suppl 1():E74-82. PubMed ID: 22213098
[TBL] [Abstract][Full Text] [Related]
12. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
13. USP7 inhibits the progression of nasopharyngeal carcinoma via promoting SPLUNC1-mediated M1 macrophage polarization through TRIM24.
Liu H; Tang L; Gong S; Xiao T; Yang H; Gu W; Wang H; Chen P
Cell Death Dis; 2023 Dec; 14(12):852. PubMed ID: 38129408
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17.
Wang LX; Kang ZP; Yang ZC; Ma RX; Tan Y; Peng XB; Dai RZ; Li J; Yu Y; Xu M
Cell Physiol Biochem; 2018; 46(6):2232-2238. PubMed ID: 29734196
[TBL] [Abstract][Full Text] [Related]
15. KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.
Guo Z; Wang Y; Yang J; Zhong J; Liu X; Xu M
Am J Otolaryngol; 2017; 38(5):511-517. PubMed ID: 28583320
[TBL] [Abstract][Full Text] [Related]
16. Circadian clock gene
Zhao C; Meng X; Li Y; Liu L; He Q; Jiang J; Chen Y; Li X; Li Y; Tang Y; Zhou D; Zhou J; Jin F
Chronobiol Int; 2022 Oct; 39(10):1340-1351. PubMed ID: 35903031
[No Abstract] [Full Text] [Related]
17. [Cellular and molecular mechanisms of anti-inflammatory effect of peroxisome proliferator-activated receptor α].
Jiao MJ; Zhou L; Ren F; Wang YD; Shen C; Duan ZP; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):916-920. PubMed ID: 28073413
[No Abstract] [Full Text] [Related]
18. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
19. Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma.
Li S; Pi G; Zeng Y; Ruan C; He X; Xiong X; Zhang M; Zou J; Liang X
Int Immunopharmacol; 2022 Dec; 113(Pt A):109323. PubMed ID: 36279666
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
